Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Poorva Bindal, M.B.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Xu W, Piper-Vallillo AJ, Bindal P, Wischhusen J, Patel JM, Costa DB, Peters MLB. Time to SARS-CoV-2 clearance among patients with cancer and COVID-19. Cancer Med. 2021 03; 10(5):1545-1549. PMID: 33560590.
    Citations:    Fields:    Translation:HumansPHPublic Health
  2. Sehgal K, Gill RR, Widick P, Bindal P, McDonald DC, Shea M, Rangachari D, Costa DB. Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy. JAMA Netw Open. 2021 02 01; 4(2):e2037120. PMID: 33570575.
    Citations:    Fields:    Translation:Humans
  3. Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird WC, Bauer KA, Zwicker JI. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020 09 10; 136(11):1342-1346. PMID: 32766883.
    Citations: 24     Fields:    Translation:HumansCellsPHPublic Health
  4. Patell R, Bogue T, Bindal P, Koshy A, Merrill M, Aird WC, Bauer KA, Zwicker JI. Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19. J Thromb Haemost. 2020 09; 18(9):2349-2357. PMID: 32692862.
    Citations: 12     Fields:    Translation:Humans
  5. Xu W, Piper-Vallillo AJ, Bindal P, Wischhusen J, Patel JM, Costa DB, Peters MLB. Time to SARS-CoV-2 Clearance Among Patients with Cancer and COVID-19. medRxiv. 2020 Jul 24. PMID: 32743607.
    Citations:    
  6. Patell R, Khan AM, Bogue T, Merrill M, Koshy A, Bindal P, Joyce R, Aird WC, Neuberg D, Bauer KA, Zwicker JI. Heparin induced thrombocytopenia antibodies in Covid-19. Am J Hematol. 2020 Jul 13. PMID: 32658337.
    Citations: 11     Fields:    
  7. Kethireddy N, Thomas S, Bindal P, Shukla P, Hegde U. Multiple autoimmune side effects of immune checkpoint inhibitors in a patient with metastatic melanoma receiving pembrolizumab. J Oncol Pharm Pract. 2021 Jan; 27(1):207-211. PMID: 32390537.
    Citations:    Fields:    Translation:Humans
  8. Bindal P, Desai A, Delasos L, Mulay S, Vredenburgh J. Primary Bone Lymphoma: A Case Series and Review of Literature. Case Rep Hematol. 2020; 2020:4254803. PMID: 32328322.
    Citations: 1     
  9. Mathew Thomas V, Alexander SA, Bindal P, Vredenburgh J. Idiopathic Granulomatous Mastitis-A Mystery Yet to be Unraveled: A Case Series and Review of Literature. Cureus. 2020 Feb 05; 12(2):e6895. PMID: 32195062.
    Citations: 3     
  10. Noor A, Bindal P, Ramirez M, Vredenburgh J. Chordoma: A Case Report and Review of Literature. Am J Case Rep. 2020 Jan 23; 21:e918927. PMID: 31969553.
    Citations: 1     Fields:    Translation:Humans
  11. Mathew Thomas V, Bindal P, Ann Alexander S, McDonald K. Nivolumab-induced hepatitis: A rare side effect of an immune check point inhibitor. J Oncol Pharm Pract. 2020 Mar; 26(2):459-461. PMID: 30909794.
    Citations: 4     Fields:    Translation:Humans
  12. McAuliffe A, Bindal P, Haley M, Vredenburgh J. Treatment exceeds expectations in a patient with non-small cell lung adenocarcinoma with an EGFR exon 20 mutation. J Oncol Pharm Pract. 2020 Jan; 26(1):206-208. PMID: 30760168.
    Citations:    Fields:    Translation:Humans
  13. Mathew Thomas V, Bindal P, Vredenburgh JJ. Everolimus and Bevacizumab in the Management of Recurrent, Progressive Intracranial NF2 Mutated Meningioma. Case Rep Oncol. 2019 Jan-Apr; 12(1):126-130. PMID: 31043950.
    Citations: 1     
  14. Bindal P, Jalil SA, Holle LM, Clement JM. Potential role of rituximab in metastatic castrate-resistant prostate cancer. J Oncol Pharm Pract. 2019 Sep; 25(6):1509-1511. PMID: 30092742.
    Citations: 2     Fields:    Translation:Humans
  15. Shukla P, Bindal P, Gupta A, Lohr JW, Arora P. Quiz page March 2015: unexplained kidney failure in a patient with bladder cancer. AKI secondary to metastatic infiltration of the kidneys by poorly differentiated urothelial cancer. Am J Kidney Dis. 2015 Mar; 65(3):A17-9. PMID: 25704048.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Bindal's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (60)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.